Author Archives: Kat

Levin Sports Plus

Levin Website

Levin is developing a unique proprietary line of medicinal cannabis products called “Levin TM”.

Levin is aimed at active and retired athletes suffering from a range of chronic pain indications, related to their sports activity.

Chronic pain is the largest target ailment globally for medicinal cannabis products, in some markets accounting for as much as 80% of prescriptions.

There is growing clinical evidence for the analgesic benefits of cannabis medicines, without the addiction problems associated with opioid painkillers.

Levin is based on a unique cannabinoid formulation developed for both its analgesic and anti-inflammatory properties.

Levin is preparing to undertake a world first clinical trial with a cohort of retired athletes, suffering from chronic pain as a result of their sports history.

Levin plans to increasingly target its medicinal cannabis products for specific patient cohorts and indications.

Levin and Zelira in New Partnership

Levin News

Levin is proud to announce a new partnership with Zelira Therapeutics to conduct a study into novel treatments for chronic pain in retired athletes.

Levin growing changes name to Levin Health

Levin Logo

Levin Growing Pty Ltd is pleased to announce that we are changing our name to Levin Health Ltd.

Over the last few years we have grown considerably, and our new name, Levin Health, reflects our expanded interests in the cannabis and healthcare industries. As we continue to build our state-of-the-art cultivation facility, we are beginning clinical trials in North America with our partners and we hope to bring new products to patients in Australia and the rest of the world soon.